CAMBRIDGE, Mass., Sept. 13 /PRNewswire-FirstCall/ -- Infinity Pharmaceuticals, Inc. (Nasdaq: INFI - News) announced today the completion of its previously announced merger with Discovery Partners International, Inc., or DPI. The newly-combined company will operate as Infinity Pharmaceuticals, Inc. under Infinity’s management and will retain no Discovery Partners operations or programs. Infinity begins trading today on the NASDAQ Global Market under the symbol “INFI.” The company will be hosting an investor conference call providing a business overview of the combined company and a discussion of its lead oncology programs on Thursday, September 14, 2006 at 8:30 a.m. EDT (5:30 a.m. PDT).
